Home 主打产品 植物提取物 天然提取物 产品目录 产品解决方案 展会 联系我们
沙棘果油seabuckthorn berry oil
姜黄素Turmeric Root Extract curcumin
胡椒碱piperine
阿尔法熊果甙alpha arbutin
唾液酸sialic acid
氨基丁酸γ-aminobutyric acid
红曲米提取物Red yeast extract
红景天提取物Rhodiola Rosea Extract
苹果提取物Apple peel extract
虫草素cordycepin
紫锥菊提取物Echinacea extract
石榴皮提取物Pomegranate exract
橄榄叶提取物olive leaf extract
荷叶提取物lotus leaf extract
常春藤提取物Ivy leaf extract
积雪草提取物centella asiatic extract
羟基积雪草苷madecassoside
积雪草甙Asiaticoside
羟基积雪草酸madecassic acid
积雪草总甙Centella total glucosides
当归提取物angelica extract
大蒜提取物garlic extract
淫羊藿提取物Epimedium extract icariin
问荆提取物Horsetail extract
黄芪提取物Astragalus extract
猴头菇提取物lion's mane mushroom extract
麦苗汁粉wheat grass juice powder
绞股蓝提取物gynostemma pentaphyllum extract
覆盆子提取物raspberry extract
水飞蓟提取物milk thistle extract
灵芝提取物Reishi Mushroom Extract
人参提取物ginseng extract
大黄素Emodin

石榴皮提取物Pomegranate exract 

石榴皮提取物

中文名:石榴皮提取物

外文名:Pomegranate peel extract

类    别:保健品原料

 提取部位:果皮,石榴籽

性状:棕黄色粉末

 用途:医药保健品,饮料食品添加剂等 

有效成分:鞣花酸

 

【产品名称】 石榴皮提取物鞣花酸

【英文名称】 Pomegranate P.E.

【分析指标】 鞣花酸

【药用部位】 果皮

【外 观】 灰色粉末

【含 量】 鞣花酸40%

【检测方法】 HPLC

【产品来源】 为石榴科植物石榴的干燥果皮。

【药理作用】 防治结肠癌,食管癌、肝癌、肺癌、及舌和皮肤肿瘤等病症;可增强人体免疫功能;有降压、镇静功效。用于医药及化妆品,作抗氧剂,具有 及抑制病毒作用。

1. 作用,鞣花酸可以抑制致癌剂的代谢活性,解除致癌物的毒性等。

2. 对人体免疫缺陷病毒的抑制作用

3. 抗氧化作用

4. 增白作用

5.降压、镇静作用

产品详询:13657416805

参考文献:

 

  1. 1.

    De Pauw-Gillet MC, Houssier C, Fredericq E (1979) Interaction of DNA and purine nucleosides with cis-dichlorodiammineplatinum(II) and antimitotic activity of the complexes on meristematic root cells. Chem Biol Interact 25:87–102

  2. 2.

    Güneri EA, Serbetçiogllu B, Ikiz AO, Güneri A, Ceryan K (2001) TEOAE monitoring of cisplatin induced ototoxicity in guinea pigs: the protective effect of vitamin B treatment. Auris Nasus Larynx 28:9–14

  3. 3.

    Nagy JL, Adelstein DJ, Newman CW, Rybicki LA, Rice TW, Lavertu P (1999) Cisplatin ototoxicity: the importance of baseline audiometry. Am J Clin Oncol 28:305–308

  4. 4.

    Rybak LP, Mukherjea D, Jajoo S, Ramkumar V (2009) Cisplatin ototoxicity and protection: clinical and experimental studies. Tohoku J Exp Med 219(3):177–186

  5. 5.

    Laurell G, Bagger-Sjoback D (1991) Dose-dependent inner ear changes after i.v. administration of cisplatin. J Otolaryngol 20:158–167

  6. 6.

    de Freitas MR, de Castro Brito GA, de Carvalho JV Jr, Gomes RM Jr, Barreto Martins MJ, de Albuquerque Ribeiro R (2009) Light microscopy study of cisplatin-induced ototoxicity in rats. J Laryngol Otol 123(6):590–597

  7. 7.

    Lopez-Gonzalez MA, Guerrero JM, Rojas F, Delgado F (2000) Ototoxicity caused by cisplatin is ameliorated by melatonin and other antioxidants. J Pineal Res 28(2):73–80

  8. 8.

    Daldal A, Odabasi O, Serbetcioglu B (2007) The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigs. Otolaryngol Head Neck Surg 137(5):747–752

  9. 9.

    Kalkanis JG, Whitworth C, Rybak LP (2004) Vitamin E reduces cisplatin ototoxicity. Laryngoscope 114(3):538–542

  10. 10.

    Kasse CA, Cruz OL, Iha LC, Costa HO, Lopes EC, Coelho F (2008) The use of Maytenus ilicifolia to prevent cisplatin-induced ototoxicity. Braz J Otorhinolaryngol 74(5):712–717

  11. 11.

    Feghali JG, Liu W, Van De Water TR (2001) L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity. Laryngoscope 111(7):1147–1155 

  12. 12.

    Lynch ED, Gu R, Pierce C, Kil J (2005) Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen. Hear Res 201(1–2):81–89

  13. 13.

    Campbell KC, Meech RP, Rybak LP, Hughes LF (1999) D-Methionine protects against cisplatin damage to the stria vascularis. Hear Res 138(1–2):13–28

  14. 14.

    Kelly TC, Whitworth CA, Husain K, Rybak LP (2003) Aminoguanidine reduces cisplatin ototoxicity. Hear Res 186(1–2):10–16

  15. 15.

    Fetoni AR, Quaranta N, Marchese R, Cadoni G, Paludetti G, Sergi B (2004) The protective role of tiopronin in cisplatin ototoxicity in Wistar rats. Int J Audiol 43(8):465–470

  16. 16.

    Huang X, Whitworth CA, Rybak LP (2007) Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats. Otol Neurotol 28(6):828–833

  17. 17.

    Teranishi MA, Nakashima T (2003) Effects of trolox, locally applied on round windows, on cisplatin-induced ototoxicity in guinea pigs. Int J Pediatr Otorhinolaryngol 67(2):133–139

  18. 18.

    Malik A, Afaq F, Sarfaraz S, Adhami VM, Syed DN, Mukhtar H (2005) Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci USA 102(41):14813–14818

  19. 19.

    Esmaillzadeh A, Tahbaz F, Gaieni I, Alavi-Majd H, Azadbakht L (2006) Cholesterol-lowering effect of concentrated pomegranate extract consumption in typeII diabetic patients with hyperlipidemia. Int J Vitam Nutr Res 76:147–151

  20. 20.

    de Nigris F, Williams-Ignarro S, Sica V et al (2007) Effects of a pomegranate fruit extract rich in punicalagin on oxidation-sensitive genes and eNOS activity at sites of perturbed shear stress and atherogenesis. Cardiovasc Res 73:414–423

  21. 21.

    Tugcu V, Kemahli E, Ozbek E et al (2008) Protective effect of a potent antioxidant, pomegranate extract, in the kidney of rats with nephrolithiasis induced by ethylene glycol. J Endourol 22:2723–2731

  22. 22.

    Aviram M, Dornfeld L (2001) Pomegranate extract consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis 158:195–198

  23. 23.

    Aviram M, Dornfeld L, Kaplan M et al (2002) Pomegranate extract flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans. Drugs Exp Clin Res 28:49–62

  24. 24.

    Cardinaal RM, Groot JCMJ, Huizing EH, Veldman JE, Smmorenbrg GF (2000) Dose-depend effect of 8-day ciplatin administration upon the morphology of the albino guinea pig cochlea. Hear Res 144:135–146

  25. 25.

    Rybak LP, Whitworth MA, Somani S (1999) Application of antioxidants and other agents to prevent ciplatin ototoxicity. Laryngoscope 109:1740–1744

  26. 26.

    Tzulker R, Glazer I, Bar-Ilan I, Holland D, Aviram M, Amir R (2007) Antioxidant activity, polyphenol content, and related compounds in different fruit juices and homogenates prepared from 29 different pomegranate accessions. J Agric Food Chem 55:9559–9570

  27. 27.

    Viuda-Martos M, Ruiz-Navajas Y, Fernandez-Lopez J, Sendra E, Sayas-Barbera E, Perez-Alvarez JA (2010) Antioxidant properties of pomegranate (Punica granatum L.) bagasses obtained as co-product in the juice extraction. Food Res Int. 

  28. 28.

    Poyrazoglu E, Gökmen V, Artik N (2002) Organic acids and phenolic compounds in pomegranates (Punica granatum L.) grown in Turkey. J Food Compos Anal 15:567–575

  29. 29.

    Fischer UA, Carle R, Kammerer DR (2011) Identification and quantification of phenolic compounds from pomegranates (Punica granatum L.) peel, mesocarp, aril and differently produced juices by HPLC-DAD-ESI/MSn. Food Chem 127:807–821

  30. 30.

    Clerici WJ, DiMartino DL, Prasad MR (1995) Direct effects of reactive oxygen species on cochlear outer hair cell shape in vitro. Hear Res 84:30–40

  31. 31.

    Rybak LP (2007) Mechanisms of cisplatin ototoxicity and progress in otoprotection. Curr Opin Otolaryngol Head Neck Surg 15:364–369

  32. 32.

    De Vita VT Jr (1997) Principles of cancer management: chemotherapy. In: De Vita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 5th edn. Lippincott-Raven, Philadelphia, pp 333–347

  33. 33.

    Rybak LP, Whitworth CA, Mukherjea D, Ramkumar V (2007) Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res 226(1–2):157–167


Home  |  主打产品  |  植物提取物  |  天然提取物  |  产品目录  |  产品解决方案  |  展会  |  联系我们  |  网站地图  |  手机版
  English     简体版     繁體版
网站首页联系我们网站地图